在疼痛性糖尿病神经病变中准N-甲基-D-酸盐2B受体 - 机制,挑战和新兴治疗方法
Nayab Khalid1, Nazlahshaniza Shafin2, Idris Long3
1Department of Physiology, Islam Medical College, Sialkot City 51040, Punjab, Pakistan.
World journal of diabetes
|January 29, 2026
概括
疼痛性糖尿病神经病变 (PDN) 涉及N-甲基-D-酸盐受体 (NMDARs),特别是NR2B亚型. 准NMDAR-2B为开发有效PDN治疗提供了一个有前途的战略.
科学领域:
- 神经科学是一个神经科学.
- 糖尿病学 糖尿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 疼痛性糖尿病神经病变 (PDN) 是糖尿病的一个常见并发症.
- 由于慢性疼痛和感官功能障碍,PDN显著降低了患者的生活质量.
- 由于其复杂的病理生理学,目前的PDN管理具有挑战性.
研究的目的:
- 审查N-甲基-D-酸盐受体 (NMDARs) 的机制作用,特别是NR2B亚型 (NMDAR-2B),在PDN.
- 探索NMDAR-2B如何与PDN中的炎症媒介,细胞质和氧化应激相互作用.
- 讨论针对NMDAR-2B的潜力,以改善PDN治疗策略.
主要方法:
- 文献审查侧重于NMDAR-2B参与PDN.
- 对NMDAR-2B在疼痛通路上调节的分析.
- 检查NMDAR-2B,炎症,质细胞和氧化应激之间的相互作用.
主要成果:
- 在PDN的病理生理学中,NMDAR-2B起着至关重要的作用.
- NMDAR-2B在疼痛处理区域上升调节,并与关键的病理媒介相互作用.
- 准NMDAR-2B为PDN管理提供了一种机械驱动的方法.
结论:
- NMDAR-2B是PDN的一个重要贡献者.
- 了解NMDAR-2B的作用可以了解PDN机制.
- 针对NMDAR-2B具有新且有效的PDN治疗的潜力.
更多相关视频
相关概念视频
Transducer Mechanism: Nuclear Receptors
2.5K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.5K
Emerging Adulthood
676
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
676
Transducer Mechanism: G Protein–Coupled Receptors
4.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.1K
Transducer Mechanism: Enzyme-Linked Receptors
4.0K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.0K
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
Pathophysiology of Diabetes
3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K


